Soluplus® as an effective absorption enhancer of poorly soluble drugs in vitro and in vivo

European Journal of Pharmaceutical Sciences

Volumn 45, Issue 3, 2012, Pages 336-343

  Linn, Michael ^a   Collnot, Eva Maria ^a,b   Djuric, Dejan ^c   Hempel, Katja ^c   Fabian, Eric ^c   Kolter, Karl ^c   Lehr, Claus Michael ^a,b  

^a SAARLAND UNIVERSITY   (Germany)

^b SAARLAND UNIVERSITY   (Germany)

^c BASF SE   (Germany)

Author keywords

Bioavailability; Caco 2; Danazol; Extrusion; Fenofibrate; Itraconazole

Indexed keywords

DANAZOL; EXCIPIENT; FENOFIBRATE; ITRACONAZOLE;

ANIMAL EXPERIMENT; AREA UNDER THE CURVE; ARTICLE; CONTROLLED STUDY; DISPERSION; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG SOLUBILITY; DRUG TRANSPORT; FEMALE; IN VITRO STUDY; IN VIVO STUDY; MAXIMUM PLASMA CONCENTRATION; NONHUMAN; PRIORITY JOURNAL;

ADMINISTRATION, ORAL; ANIMALS; AREA UNDER CURVE; BIOLOGICAL AVAILABILITY; BIOLOGICAL TRANSPORT; CACO-2 CELLS; DANAZOL; DOGS; EXCIPIENTS; FEMALE; FENOFIBRATE; HUMANS; INTESTINAL ABSORPTION; ITRACONAZOLE; PHARMACEUTICAL PREPARATIONS; POLYETHYLENE GLYCOLS; POLYVINYLS; SOLUBILITY;

EID: 84855764431     PISSN: 09280987     EISSN: 18790720     Source Type: Journal    
DOI: 10.1016/j.ejps.2011.11.025     Document Type: Article

References (45)

1. G.L. Amidon, H. Lennernas, V.P. Shah, and J.R. Crison A theoretical basis for a biopharmaceutic drug classification: The correlation of in vitro drug product dissolution and in vivo bioavailability Pharm Res 12 1995 413 420
2. P. Artursson Epithelial transport of drugs in cell culture. I: A model for studying the passive diffusion of drugs over intestinal absorbtive (Caco-2) cells J Pharm Sci 79 1990 476 482 (Pubitemid 20221389)
3. P. Artursson, K. Palm, and K. Luthman Caco-2 monolayers in experimental and theoretical predictions of drug transport Adv Drug Deliver Rev 46 2001 27 43
4. D. Balayssac, N. Authier, A. Cayre, and F. Coudore Does inhibition of P-glycoprotein lead to drug-drug interactions? Toxicol Lett 156 2005 319 329 (Pubitemid 40342565)
5. J. Balfour, D. McTavish, and R. Heel Fenofibrate: A Review of its Pharmacodynamic and Pharmacokinetic Properties and Therapeutic Use in Dyslipidaemia Drugs 40 1990 260 290
6. BASF, 2010. Soluplus - Technical Information.
7. R.R. Brodie, L.F. Chasseaud, and F.F. Elson Antilipidemic drugs. Part IV: The metabolic fate of the hypolipidemic agent isopropyl [4' (p chlorobenzoyl) 2 phenoxy 2 methyl] propionate (LF 178) in rats, dogs and man Arzneimittel-Forsch 26 1976 896 901
8. P. Buch, P. Langguth, M. Kataoka, and S. Yamashita IVIVC in oral absorption for fenofibrate immediate release tablets using a dissolution/permeation system J Pharm Sci 98 2009 2001 2009
9. C.M. Buchanan, N.L. Buchanan, K.J. Edgar, S. Klein, J.L. Little, M.G. Ramsey, K.M. Ruble, V.J. Wacher, and M.F. Wempe Pharmacokinetics of itraconazole after intravenous and oral dosing of itraconazole-cyclodextrin formulations J Pharm Sci 96 2007 3100 3116 (Pubitemid 350221205)
10. W.M. Buckett, A. Saleh, T. Tulandi, and S.L. Tan Endometriosis: Critical assessment of current therapies Curr Obstet Gynaecol 8 1998 204 208 (Pubitemid 128674457)
11. M. Chapman Pharmacology of fenofibrate Am J Med 83 1987 21 25
12. W.N. Charman, M.C. Rogge, A.W. Boddy, and B.M. Berger Effect of food and a monoglyceride emulsion formulation on danazol bioavailability J Clin Pharmacol 33 1993 381 386 (Pubitemid 23141537)
13. K. Chu, and S. Yalkowsky An interesting relationship between drug absorption and melting point Int J Pharm 373 2009 24 40
14. E.M. Collnot, C. Baldes, M.F. Wempe, J. Hyatt, L. Navarro, K.J. Edgar, U.F. Schaefer, and C.M. Lehr Influence of vitamin E TPGS poly(ethylene glycol) chain length on apical efflux transporters in Caco-2 cell monolayers J Control Release 111 2006 35 40 (Pubitemid 43289992)
15. K. De Beule, and J. Van Gestel Pharmacology of itraconazole Drugs 61 2001 27 37 (Pubitemid 32151110)
16. J.M. Dintaman, and J.A. Silverman Inhibition of P-glycoprotein by D-alpha-tocopheryl polyethylene glycol 1000 succinate (TPGS) Pharm Res 16 1999 1550 1556 (Pubitemid 29510551)
17. J.B. Dressman, and C. Reppas In vitro-in vivo correlations for lipophilic, poorly water-soluble drugs Eur J Pharm Sci 11 2000 S73 S80
18. H. Hardung, D. Djuric, and S. Ali Combining HME & solubilization: Soluplus® - The solid solution Drug Deliv Tech 10 2010 20 27
19. J.-Y. Hong, J.-K. Kim, Y.-K. Song, J.-S. Park, and C.-K. Kim A new self-emulsifying formulation of itraconazole with improved dissolution and oral absorption J Control Release 110 2006 332 338 (Pubitemid 41827486)
20. J. Hu, K.P. Johnston, and R.O. Williams III Rapid dissolving high potency danazol powders produced by spray freezing into liquid process Int J Pharm 271 2004 145 154 (Pubitemid 38210092)
21. S. Jaruratanasirikul, and S. Sriwiriyajan Effect of omeprazole on the pharmacokinetics of itraconazole Eur J Clin Pharmacol 54 1998 159 161 (Pubitemid 28204270)
22. B.M. Johnson, W.N. Charman, and C.J.H. Porter An in vitro examination of the impact of polyethylene glycol 400, Pluronic P85, and vitamin E d-α-tocopheryl polyethylene glycol 1000 succinate on P-glycoprotein efflux and enterocyte-based metabolism in excised rat intestine AAPS PharmSci 4 2002 193 205
23. H. Komura, and M. Iwaki Pitfalls in high throughput screening for drug absorption optimization in drug discovery Curr Anal Chem 3 2007 302 309
24. C. Leuner, and J. Dressman Improving drug solubility for oral delivery using solid dispersions Eur J Pharm Biopharm 50 2000 47 60 (Pubitemid 30326688)
25. C.A. Lipinski, F. Lombardo, B.W. Dominy, and P.J. Feeney Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings Adv Drug Deliver Rev 23 1997 3 25 (Pubitemid 27046991)
26. G.G. Liversidge, and K.C. Cundy Particle size reduction for improvement of oral bioavailability of hydrophobic drugs: I. Absolute oral bioavailability of nanocrystalline danazol in beagle dogs Int J Pharm 125 1995 91 97
27. R. Mellaerts, R. Mols, P. Kayaert, P. Annaert, J. Van Humbeeck, G. Van den Mooter, J.A. Martens, and P. Augustijns Ordered mesoporous silica induces pH-independent supersaturation of the basic low solubility compound itraconazole resulting in enhanced transepithelial transport Int J Pharm 357 2008 169 179
28. X. Meng, Y. Chen, S.R. Chowdhury, D. Yang, and S. Mitra Stabilizing dispersions of hydrophobic drug molecules using cellulose ethers during anti-solvent synthesis of micro-particulates Colloids Surface B 70 2009 7 14
29. D.A. Miller, J.C. DiNunzio, W. Yang, J.W. McGinity, and R.O. Williams III Targeted intestinal delivery of supersaturated itraconazole for improved oral absorption Pharm Res 25 2008 1450 1459
30. M. Oda, H. Saitoh, M. Kobayashi, and B.J. Aungst β-Cyclodextrin as a suitable solubilizing agent for in situ absorption study of poorly water-soluble drugs Int J Pharm 280 2004 95 102 (Pubitemid 38950907)
31. K.A. Overhoff, J.D. Engstrom, B. Chen, B.D. Scherzer, T.E. Milner, K.P. Johnston, and R.O. Williams III Novel ultra-rapid freezing particle engineering process for enhancement of dissolution rates of poorly water-soluble drugs Eur J Pharm Biopharm 65 2007 57 67 (Pubitemid 44827696)
32. J. Peeters, P. Neeskens, J.P. Tollenaere, P.V. Remoortere, and M.E. Brewster Characterization of the interaction of 2-hydroxypropyl-beta- cyclodextrin with itraconazole at pH 2, 4, and 7 J Pharm Sci 91 2002 1414 1422
33. B.E. Rabinow Nanosuspensions in drug delivery Nat Rev Drug Discov 3 2004 785 796 (Pubitemid 39242830)
34. B.D. Rege, J.P. Kao, and J.E. Polli Effects of nonionic surfactants on membrane transporters in Caco-2 cell monolayers Eur J Pharm Sci 16 2002 237 246
35. V. Sant, D. Smith, and J.-C. Leroux Enhancement of oral bioavailability of poorly water-soluble drugs by poly(ethylene glycol)-block-poly(alkyl acrylate-co-methacrylic acid) self-assemblies J Control Release 104 2005 289 300 (Pubitemid 40724930)
36. R. Sauron, M. Wilkins, V. Jessent, A. Dubois, C. Maillot, and A. Weil Absence of a food effect with a 145 mg nanoparticle fenofibrate tablet formulation Int J Clin Pharmacol Ther 44 2006 64 70 (Pubitemid 43230588)
37. L.E. Schmidt, and K. Dalhoff Food-drug interactions Drugs 62 2002 1481 1502 (Pubitemid 34804156)
38. R.B. Shah, A. Palamakula, and M.A. Khan Cytotoxicity Evaluation of Enzyme Inhibitors and Absorption Enhancers in Caco-2 Cells for Oral Delivery of Salmon Calcitonin J Pharm Sci 93 2004 1070 1082 (Pubitemid 38420417)
39. K. Six, H. Berghmans, C. Leuner, J. Dressman, K. Van Werde, J. Mullens, L. Benoist, M. Thimon, L. Meublat, G. Verreck, J. Peeters, M. Brewster, and G. Van den Mooter Characterization of Solid Dispersions of Itraconazole and Hydroxypropylmethylcellulose Prepared by Melt Extrusion, Part II Pharm Res 20 2003 1047 1054 (Pubitemid 36774276)
40. Y. Takahashi, H. Kondo, T. Yasuda, T. Watanabe, S.-I. Kobayashi, and S. Yokohama Common solubilizers to estimate the Caco-2 transport of poorly water-soluble drugs Int J Pharm 246 2002 85 94 (Pubitemid 35247981)
41. M.M. Thanou, J.C. Verhoef, S.G. Romeijn, J.F. Nagelkerke, F.W.H.M. Merkus, and H.E. Junginger Effects of N-trimethyl chitosan chloride, a novel absorption enhancer, on Caco-2 intestinal epithelia and the ciliary beat frequency of chicken embryo trachea International Journal of Pharmaceutics 185 1999 73 82 (Pubitemid 29333098)
42. M. Vogt, K. Kunath, and J.B. Dressman Dissolution enhancement of fenofibrate by micronization, cogrinding and spray-drying: Comparison with commercial preparations Eur J Pharm Biopharm 68 2008 283 288
43. A. Weil, J. Caldwell, and M. Strolin-Benedetti The metabolism and disposition of fenofibrate in rat, guinea pig, and dog Drug Metab Dispos 16 1988 302 309
44. S. Yamashita, T. Furubayashi, M. Kataoka, T. Sakane, H. Sezaki, and H. Tokuda Optimized conditions for prediction of intestinal drug permeability using Caco-2 cells Eur J Pharm Sci 10 2000 195 204 (Pubitemid 30190095)
45. Y. Yi, H. Yoon, B. Kim, M. Shim, S.-O. Kim, S.-J. Hwang, and M. Seo A mixed polymeric micellar formulation of itraconazole: Characteristics, toxicity and pharmacokinetics J Control Release 117 2007 59 67 (Pubitemid 46161866)